80 related articles for article (PubMed ID: 29157266)
1. Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts.
Fan H; Li H; Liu G; Cong W; Zhao H; Cao W; Zheng J
J Exp Clin Cancer Res; 2017 Nov; 36(1):163. PubMed ID: 29157266
[TBL] [Abstract][Full Text] [Related]
2. EHMT2 Suppresses ARRB1 Transcription and Activates the Hedgehog Signaling to Promote Malignant Phenotype and Stem Cell Property in Oral Squamous Cell Carcinoma.
Niu L; Hu G
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38573544
[TBL] [Abstract][Full Text] [Related]
3. Vascular Response to Low-intensity Ultrasound Stimulation.
Song H; Sun J; Miao P; Tong S
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082927
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
5. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells.
Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
Bose C; Awasthi S; Sharma R; Beneš H; Hauer-Jensen M; Boerma M; Singh SP
PLoS One; 2018; 13(3):e0193918. PubMed ID: 29518137
[TBL] [Abstract][Full Text] [Related]
7. Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells.
Jeon KH; Yu HV; Kwon Y
Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1126-1133. PubMed ID: 29425806
[TBL] [Abstract][Full Text] [Related]
8. Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant.
Casadei B; Pellegrini C; Tonialini L; Argnani L; Zinzani PL
Hematol Oncol; 2018 Apr; 36(2):489-491. PubMed ID: 29363146
[No Abstract] [Full Text] [Related]
9. Anaplastic thyroid carcinoma with rapid thyrotoxicosis - a case report and the literature review.
Daroszewski J; Paczkowska K; Jawiarczyk-Przybyłowska A; Bolanowski M; Jeleń M
Endokrynol Pol; 2018; 69(1):28-31. PubMed ID: 29319130
[TBL] [Abstract][Full Text] [Related]
10. Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.
Maruhashi R; Akizuki R; Sato T; Matsunaga T; Endo S; Yamaguchi M; Yamazaki Y; Sakai H; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):470-479. PubMed ID: 29247669
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care.
Dada R
Acta Haematol; 2017; 138(4):216-220. PubMed ID: 29212067
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience.
Ates O; Aksoy S; Yeter H; Sunar V; Kertmen N; Dizdar O; Turker A; Kars A
Indian J Cancer; 2017; 54(1):321-325. PubMed ID: 29199714
[TBL] [Abstract][Full Text] [Related]
13. Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors.
Carlson M; Watson AL; Anderson L; Largaespada DA; Provenzano PP
J Biomed Opt; 2017 Nov; 22(11):1-9. PubMed ID: 29188660
[TBL] [Abstract][Full Text] [Related]
14. Liver atrophy after percutaneous transhepatic portal embolization occurs in two histological phases: Hepatocellular atrophy followed by apoptosis.
Iwao Y; Ojima H; Kobayashi T; Kishi Y; Nara S; Esaki M; Shimada K; Hiraoka N; Tanabe M; Kanai Y
World J Hepatol; 2017 Nov; 9(32):1227-1238. PubMed ID: 29184609
[TBL] [Abstract][Full Text] [Related]
15. Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma.
Naik PP; Mukhopadhyay S; Panda PK; Sinha N; Das CK; Mishra R; Patil S; Bhutia SK
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29171106
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones.
Mielcke TR; Muradás TC; Filippi-Chiela EC; Amaral MEA; Kist LW; Bogo MR; Mascarello A; Neuenfeldt PD; Nunes RJ; Campos MM
Sci Rep; 2017 Nov; 7(1):15850. PubMed ID: 29158524
[TBL] [Abstract][Full Text] [Related]
17. Expression of Pref-1 and Related Chemokines during theDevelopment of Rat Mesenteric Lymph Nodes.
Peng Y; Jia LM; Li BX; Xie LP; Xie ZJ; Zheng JH
Biomed Environ Sci; 2018 Jul; 31(7):507-514. PubMed ID: 30145985
[TBL] [Abstract][Full Text] [Related]
18. Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment.
Song K; Yu Z; Zu X; Li G; Hu Z; Xue Y
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142424
[TBL] [Abstract][Full Text] [Related]
19. Flavonoid GL-V9 suppresses invasion and migration of human colorectal cancer cells by inhibiting PI3K/Akt and MMP-2/9 signaling.
Gu Y; Yu J; Ding C; Zhou Y; Yang J; Yu W; Zhang X; Huang H
J Cancer; 2021; 12(15):4542-4551. PubMed ID: 34149918
[TBL] [Abstract][Full Text] [Related]
20. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
